A Randomized, Phase III Study of Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab Investigating EGFR FISH in Patients with Advanced Non-Small Cell Lung Cancer: SWOG S0819

BACKGROUND: EGFR antibodies have been shown to increase survival in patients with advanced non-small cell lung cancer (NSCLC), particularly with squamous cell (SC) histology. Our prior work suggested that EGFR copy number by fluorescence in-situ hybridization (FISH) identifies patients most likely t...

詳細記述

保存先:
書誌詳細
出版年:Lancet Oncol
主要な著者: Herbst, Roy S., Redman, Mary W., Kim, Edward S., Semrad, Thomas J., Bazhenova, Lyudmila, Masters, Gregory, Oettel, Kurt, Guaglianone, Perry, Reynolds, Christopher, Karnad, Anand, Arnold, Susanne M., Varella-Garcia, Marileila, Moon, James, Mack, Philip C., Blanke, Charles D., Hirsch, Fred R., Kelly, Karen, Gandara, David R.
フォーマット: Artigo
言語:Inglês
出版事項: 2017
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5847342/
https://ncbi.nlm.nih.gov/pubmed/29169877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(17)30694-0
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料